Underneath the Gut–Brain Axis in IBD—Evidence of the Non-Obvious DOI Open Access
Lidiya V. Boldyreva, A. A. Evtushenko, Maria Lvova

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(22), P. 12125 - 12125

Published: Nov. 12, 2024

The gut–brain axis (GBA) plays a pivotal role in human health and wellness by orchestrating complex bidirectional regulation influencing numerous critical processes within the body. Over past decade, research has increasingly focused on GBA context of inflammatory bowel disease (IBD). Beyond its well-documented effects GBA–enteric nervous system vagus nerve dysregulation, gut microbiota misbalance—IBD also leads to impairments metabolic cellular functions: mitochondrial dysfunction, cationic transport, cytoskeleton dysregulation. These systemic are currently underexplored relation GBA; however, they crucial for cells’ functioning. This review summarizes studies particular mechanisms IBD. Understanding involvement these may help find new therapeutic targets develop approaches improve quality life IBD patients.

Language: Английский

Effect of Wheat Dextrin Fiber on the Fecal Microbiome and Short-Chain Fatty Acid Concentrations in Dogs: Randomized, Single-Blinded, Parallel-Group Clinical Trial DOI Open Access
Marianne Pan, Chi‐Hsuan Sung, Rachel Pilla

et al.

Deleted Journal, Journal Year: 2025, Volume and Issue: 2(1), P. 3 - 3

Published: Jan. 17, 2025

The purpose of this study was to assess the practical implications supplementing soluble fiber in diet dogs. Dogs with a history managed or active chronic enteropathy were randomized receive either wheat dextrin (fiber group) maltodextrin (placebo mixed food once daily for 28 days. Owners recorded fecal score one week prior and during supplementation period. Shallow shotgun sequencing, quantitative PCR abundances core bacterial taxa, short-chain fatty acid (SCFA) concentrations via gas chromatography/mass spectrometry performed on samples collected before after supplementation. Seventeen dogs completed group: nine dogs; placebo eight dogs). change differed between groups, group developing softer stools (p = 0.03). Alpha diversity, quantified SCFA-producing SCFA not different group. Fecal microbial communities baseline day groups 0.02, respectively); however, size effect (ANOSIM R 0.18 0.26, respectively) minimal. In small fed variable commercial diets, additional intake powder supplement well accepted, but had minimal discernable clinical benefit, could soften stools.

Language: Английский

Citations

0

Differentiating Canine Chronic Inflammatory Enteropathies Using Faecal Amino Acid Profiles: Potential and Limitations DOI Creative Commons
Cristina Higueras, Claudia Ruíz‐Capillas, Ana M. Herrero

et al.

Animals, Journal Year: 2025, Volume and Issue: 15(8), P. 1185 - 1185

Published: April 21, 2025

The aims of this study were to characterise the faecal amino acid profile dogs with different chronic digestive diseases (food-responsive enteropathy (FRE), immunosuppressant-responsive (IRE)) prior dietary change, and Giardia infection (GIA), compared healthy control (HC), evaluate their discriminating potential. HC group presented lower tyrosine (Tyr) aromatic acids (AAAs) FRE or IRE (p = 0.0001). Additionally, had levels threonine (Thr) 0.0005) than group, while showed intermediate values. No statistically significant differences in observed between dogs. In contrast, GIA higher values (except glutamic (Glu)) other most determinant variables contributing discriminant functions Tyr, Glu, arginine, phenylalanine. Validation results that 44% stool samples misclassified, resulting a 56% success rate. did not accurately distinguish from dogs; however, excretion AAs was generally GIA.

Language: Английский

Citations

0

Underneath the Gut–Brain Axis in IBD—Evidence of the Non-Obvious DOI Open Access
Lidiya V. Boldyreva, A. A. Evtushenko, Maria Lvova

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(22), P. 12125 - 12125

Published: Nov. 12, 2024

The gut–brain axis (GBA) plays a pivotal role in human health and wellness by orchestrating complex bidirectional regulation influencing numerous critical processes within the body. Over past decade, research has increasingly focused on GBA context of inflammatory bowel disease (IBD). Beyond its well-documented effects GBA–enteric nervous system vagus nerve dysregulation, gut microbiota misbalance—IBD also leads to impairments metabolic cellular functions: mitochondrial dysfunction, cationic transport, cytoskeleton dysregulation. These systemic are currently underexplored relation GBA; however, they crucial for cells’ functioning. This review summarizes studies particular mechanisms IBD. Understanding involvement these may help find new therapeutic targets develop approaches improve quality life IBD patients.

Language: Английский

Citations

1